Science is the foundation of everything we do.
In our quest to bring hope to those in need, we continuously advance our knowledge and understanding of pridopidine’s mechanism of action.
With expertise and determination, we partner with leading labs and clinicians across the globe to discover novel therapeutic avenues.
About Pridopidine
Pridopidine is an oral drug currently in development for the treatment of Huntington’s disease and ALS. It is administered in a small easy-to-swallow capsule twice a day.
Publications
Peer-reviewed publications about pridopidine's mechanism of action.